EIS on Chest Tumors 2007

TITLE	SESSION	AUTHOR
A review of adjuvant chemotherapy	Adjuvant therapy of NSCLC	Eric Vallières, US
The impact of adjuvant therapy on patients	Adjuvant therapy of NSCLC	Richard Stephens, GB
The position of neoadjuvant chemotherapy	Adjuvant therapy of NSCLC	Fabrice Barlési, FR
The biology of EGFR	Biology and molecular epidemiology of lung cancer	William Gullick, GB
The smoking epidemic and lung cancer	Biology and molecular epidemiology of lung cancer	Carlo La Vecchia, IT
A 38-year old woman, non-smoker, adenocarcinoma, multiple lung lesions.	Patient case discussion - advanced NSCLC	Benjamin Besse, FR
A 47-year old man, successfully treated with chemoradiotherapy 2 year before for stage IIIB NSCLC, with symptoms of brain metastases	Patient case discussion - advanced NSCLC	Wilfried Eberhardt, AT
A 62-year old man, with symptoms of brain metastasis and a lung tumor.	Patient case discussion - advanced NSCLC	Robert Pirker, AT
A 73-year old man, smoker, squamous carcinoma, painful femur osteolysis	Patient case discussion - advanced NSCLC	Cesare Gridelli, IT
Management of a patient with N2 involvement at staging mediastinoscopy	Patient case discussion - early NSCLC	David Waller, GB
Management of unexpected N2 positivity at resection of a small peripheral adenocarcinoma	Patient case discussion - early NSCLC	Eric Vallières, US
Which first line treatment should be given to a young female non smoker with bilateral bronchoalveolar carcinoma (bac)?	Patient case discussion - early NSCLC	Federico Cappuzzo, IT
Mesothelioma: diagnosis, staging and treatment	Rare tumors	Paul Baas, NL
Thymic malignancies and other mediastinal tumors	Rare tumors
Thymic malignancies and other mediastinal tumors	Rare tumors	Paul van Schil, NL
Advances in chemotherapy	Small cell lung cancer and carcinoids	Paris A. Kosmidis, GR
Integration of systemic therapy with radiotherapy	Small cell lung cancer and carcinoids	Corinne Faivre-Finn, GB
Endoscopic examinations	Staging	Kurt Tournoy, BE
First line therapy	Systemic therapy for advanced disease	Cesare Gridelli, IT
Selecting chemotherpy	Systemic therapy for advanced disease	Rafael Rosell, ES